According to Lineage Cell Therapeutics
's latest financial reports the company has ยฃ51.52 Million in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $ยฃ48.68 M | -18.13% |
2022-12-31 | $ยฃ59.46 M | -11.7% |
2021-12-31 | $ยฃ67.33 M | -3.51% |
2020-12-31 | $ยฃ69.78 M | -17.74% |
2019-12-31 | $ยฃ84.83 M | 16.74% |
2018-12-31 | $ยฃ72.67 M | -40.21% |
2017-12-31 | $ยฃ0.12 B | 14.91% |
2016-12-31 | $ยฃ0.10 B | 105.03% |
2015-12-31 | $ยฃ51.58 M | 28.05% |
2014-12-31 | $ยฃ40.28 M | 57.24% |
2013-12-31 | $ยฃ25.62 M | 70.46% |
2012-12-31 | $ยฃ15.03 M | -43.65% |
2011-12-31 | $ยฃ26.67 M | -16.69% |
2010-12-31 | $ยฃ32.01 M | 369% |
2009-12-31 | $ยฃ6.82 M | -330.18% |
2008-12-31 | $-ยฃ2.97 Million | 93.41% |
2007-12-31 | $-ยฃ1.54 Million | 61.04% |
2006-12-31 | $-ยฃ0.96 Million | 735.33% |
2005-12-31 | $-ยฃ0.12 Million | -163.48% |
2004-12-31 | $ยฃ0.17 M | -113.22% |
2003-12-31 | $-ยฃ1.36 Million | 86.02% |
2002-12-31 | $-ยฃ0.74 Million | 968.71% |
2001-12-31 | $-ยฃ0.07 Million |